What is MAZE's price / book?

MAZE (MAZE) reported price / book of 4.3× in Q1 2026.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

MAZE MAZE Price / book

Price / book at other companies

Vertex PharmaceuticalsVRTX

5.9×-1.7×

Septerna, Inc.SEPN

2.9×—

Stoke Therapeutics, Inc.STOK

4.9×+3.8×

Olema Pharmaceuticals, Inc.OLMA

2.7×+2.0×

ZymeworksZYME

11.4×+8.8×

Nurix Therapeutics, Inc.NRIX

3.4×+1.0×

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$26.6M+25.0%

Net income-$24.2M+26.2%

EPS (diluted)-$0.45+60.9%

Balance sheet

See full

Cash & equivalents$198.8M-32.5%

Total debt$61.2M+137%

Total equity$341.7M+17.0%

Total assets$419.7M+26.1%

Cash flow

See full

Operating cash flow-$39.1M-32.5%

CapEx$93.0K-68.9%

Free cash flow-$39.2M-31.5%

Valuation

See full

Market cap$1.48B+201%

Enterprise value$1.34B—

P/S7.9×—

Profitability

See full

Operating margin-71.5%—

Net margin-65.4%—

FCF margin-65.1%—

Returns & leverage

See full

Return on equity-38.7%—

Debt / equity0.2×+0.1×

Current ratio17.9×+1.8×

Where this comes from

Calculated from MAZE’s reported figures.

market cap/total stockholders equity=4.3×

Based on the most recent quarter.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MAZE's price / book?: MAZE (MAZE) reported price / book of 4.3× in Q1 2026.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.